Intracranial Arteriosclerosis clinical trials at University of California Health
1 research study open to eligible people
open to eligible people ages 30-80
The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, intracerebral hemorrhage, or vascular death.
at UC Davis UCLA UCSD